Literature DB >> 11328904

Procalcitonin: a new marker of inflammation in haemodialysis patients?

C Level1, P Chauveau, Y Delmas, C Lasseur, G Pellé, E Peuchant, D Montaudon, C Combe.   

Abstract

BACKGROUND: Although procalcitonin (PCT) has been described as a new marker of infection and inflammation, it has not been extensively studied in dialysis patients.
METHODS: We measured plasma PCT levels in 62 patients on maintenance haemodialysis (30 M/32 F, age 61.8+/-17.1 years, on dialysis for 75+/-93 months, 12 h/week, with a Kt/V of 1.53+/-0.31, high-flux membrane being used in 25 patients and low-flux in 37 patients, without reuse). PCT levels were compared with other markers of inflammation and nutritional status, including C-reactive protein (CRP), fibrinogen, interleukin-6 (IL-6), leukocytes, urea, creatinine, albumin, prealbumin, normalized protein catabolic rate (nPCR), haemoglobin (Hb), and epoetin (Epo) doses. Patients were divided into different groups according to their infectious and vascular status.
RESULTS: PCT plasma levels before dialysis were 0.69+/-0.81 ng/ml. Fifty-seven per cent of PCT values were higher than the upper normal limit of 0.5 ng/ml. CRP and PCT concentrations were high in patients with a current infection, while IL-6 values were elevated in all patients regardless of infection status. Plasma CRP concentrations before dialysis were 21.2+/-31.4 mg/l, and 70% of these values were higher than the upper normal limit. CRP, PCT, IL-6, and fibrinogen were positively correlated with each other and were all negatively correlated with albumin. Prealbumin was negatively correlated with CRP and IL-6. In the 43 patients treated with Epo, haemoglobin was negatively correlated with IL-6 and Epo doses, while Epo doses were positively correlated with IL-6 but not with CRP or PCT. The 23 patients with both elevated PCT and CRP plasma levels had the lowest Hb, albumin, and prealbumin concentrations, and the highest fibrinogen concentrations and Epo doses.
CONCLUSION: PCT in haemodialysis patients is positively correlated with currently used markers of inflammation such as CRP and fibrinogen, and negatively correlated with markers of nutritional status such as albumin. The concomitant elevations in PCT and CRP could be more sensitive in the evaluation of inflammation than each marker separately.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328904     DOI: 10.1093/ndt/16.5.980

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Persistent visual loss as a complication of meningococcal meningitis.

Authors:  Limangeni A Mankhambo; Nick V Makwana; Enitan D Carrol; Nick A Beare; Terrie Taylor; Sam Kampondeni; Elizabeth M Molyneux
Journal:  Pediatr Infect Dis J       Date:  2006-06       Impact factor: 2.129

2.  Procalcitonin serum levels in children undergoing chronic haemodialysis.

Authors:  Fleur Lorton; Frédérique Veinberg; Dominique Ielsch; Georges Deschênes; Albert Bensman; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2006-10-17       Impact factor: 3.714

Review 3.  Clinical Utility and Measurement of Procalcitonin.

Authors:  Intan Samsudin; Samuel D Vasikaran
Journal:  Clin Biochem Rev       Date:  2017-04

4.  Diagnostic Value of Simultaneous Measurement of Procalcitonin, Interleukin-6 and hs-CRP in Prediction of Early-Onset Neonatal Sepsis.

Authors:  Alireza Abdollahi; Saeed Shoar; Fatemeh Nayyeri; Mamak Shariat
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-06       Impact factor: 2.576

5.  Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.

Authors:  Wan Soo Lee; Dae Woong Kang; Jong Hun Back; Hyun Lee Kim; Jong Hoon Chung; Byung Chul Shin
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

6.  Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment.

Authors:  Dena El-Sayed; Jonathan Grotts; William A Golgert; Alan M Sugar
Journal:  Open Forum Infect Dis       Date:  2014-08-21       Impact factor: 3.835

7.  The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics.

Authors:  Iram Yunus; Anum Fasih; Yanzhi Wang
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

8.  Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.

Authors:  Claude Level; Philippe Chauveau; Olivier Guisset; Marie Cécile Cazin; Catherine Lasseur; Claude Gabinsky; Stéphane Winnock; Danièle Montaudon; Régis Bedry; Caroline Nouts; Odile Pillet; Georges Gbikpi Benissan; Jean Claude Favarel-Guarrigues; Yves Castaing
Journal:  Crit Care       Date:  2003-10-02       Impact factor: 9.097

9.  Prognostic Value of Serum Procalcitonin level for the Diagnosis of Bacterial Infections in Critically-ill Patients.

Authors:  Apichot So-Ngern; Sombat Leelasupasri; Suvatna Chulavatnatol; Chalermsri Pummangura; Pakwan Bunupuradah; Preecha Montakantikul
Journal:  Infect Chemother       Date:  2019-09

10.  The Relationship between Serum Procalcitonin and Dialysis Adequacy in Peritoneal Dialysis Patients.

Authors:  Benyong Wang; Chan Gao; Qi Chen; Ming Wang; Xiao Fei; Ning Zhao
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.